IMEX 05356
INSTITUTO DE MEDICINA EXPERIMENTAL
Unidad Ejecutora - UE
congresos y reuniones científicas
Título:
Biological consequences of the use of BTK and BCL-2 inhibitors and therapeutic MoAbs against SLAMF7 and CD38
Autor/es:
GAMBERALE ROMINA
Lugar:
Orlando
Reunión:
Encuentro; Evolution on B cell malignancies treatment. ASH Dinner 2015; 2015
Institución organizadora:
Janssen Global
Resumen:
Biological consequences of the use of BTK and BCL-2 inhibitors and therapeutic MoAbs against SLAMF7 and CD38
